Not applicableLooking for participantsNCT01605266What this trial is testingINSIGHT (Insight Into Nephrotic Syndrome)Who this might be right forNephrotic Syndrome The Hospital for Sick Children 1,000
Not applicableUnknownNCT06443034What this trial is testingPredictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease Assistance Publique - Hôpitaux de Paris 124
Testing effectiveness (Phase 2)Looking for participantsNCT06500702What this trial is testingEvaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion Sanofi 84
Not applicableLooking for participantsNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375
Testing effectiveness (Phase 2)WithdrawnNCT05599815What this trial is testingPart 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWho this might be right forNephrotic Syndrome Aldeyra Therapeutics, Inc.
Not applicableLooking for participantsNCT07010250What this trial is testingEpithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisWho this might be right forANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Ended earlyNCT04950114What this trial is testingAn Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney DiseasesWho this might be right forKidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more Goldfinch Bio, Inc. 31
Not applicableLooking for participantsNCT06334692What this trial is testingAutoantibodies Against-nephrin in Idiopathic Nephrotic SyndromeWho this might be right forNephrotic Syndrome Mario Negri Institute for Pharmacological Research 100
Not applicableUnknownNCT05797051What this trial is testingApplication of Hyperspectral Imaging in the Diagnosis of Glomerular DiseasesWho this might be right forGlomerulonephritis, IGAGlomerulonephritis, MembranousDiabetic Nephropathies+2 more Qianfoshan Hospital 80
Post-approval studies (Phase 4)UnknownNCT01346007What this trial is testingStudy of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic SyndromeWho this might be right forIdiopathic Nephrotic Syndrome National and Kapodistrian University of Athens 50
Not applicableLooking for participantsNCT03949972What this trial is testingThe FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)Who this might be right forGlomerulosclerosis, Focal SegmentalMinimal Change DiseaseIdiopathic Nephrotic Syndrome Prof. Dr. Paul Brinkkoetter 500
Early research (Phase 1)Study completedNCT05314231What this trial is testingSafety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With ProteinuriaWho this might be right forProteinuria Alexion Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT04369183What this trial is testingRituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change Disease Istanbul University 25
Large-scale testing (Phase 3)Study completedNCT00065611What this trial is testingSteroid Treatment for Kidney DiseaseWho this might be right forNephrosisFocal Lipoid Glomerulosclerosis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8
Not applicableLooking for participantsNCT01209000What this trial is testingNephrotic Syndrome Study NetworkWho this might be right forMinimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental University of Michigan 1,200